BACKGROUND AND METHODS. Experiments in animals and two epidemiologic studies in humans suggest that aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs) may be protective against colon cancer. We tested this hypothesis in a prospective mortality study of 662,424 adults who provided information in 1982 on the frequency and duration of their aspirin use. Death rates from colon cancer were measured through 1988. The possible influence of other risk factors for colon cancer was examined in multivariate analyses for 598 case patients and 3058 matched control subjects drawn from the cohort. RESULTS. Death rates from colon cancer decreased with more frequent aspirin use in both men and women. The relative risk among persons who used aspirin 16 or more times per month for at least one year was 0.60 in men (95 percent confidence interval, 0.40 to 0.89) and 0.58 in women (95 percent confidence interval, 0.37 to 0.90). The risk estimates were unaffected when we excluded persons who reported at entry into the study that they had cancer, heart disease, stroke, or another condition that might influence both their aspirin use and their mortality. Adjustment for dietary factors, obesity, physical activity, and family history did not alter the findings significantly. No association was found between the use of acetaminophen and the risk of colon cancer. CONCLUSIONS. Regular aspirin use at low doses may reduce the risk of fatal colon cancer. Whether this is due to a direct effect of aspirin, perhaps mediated by the inhibition of prostaglandin synthesis, or to other factors indirectly associated with aspirin use is unclear.
Source Information
Department of Epidemiology and Statistics, American Cancer Society, Atlanta, GA 30329.
This article has been cited by other articles:
Miyaki, A., Yang, P., Tai, H.-H., Subbaramaiah, K., Dannenberg, A. J.
(2009). Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. Am. J. Physiol. Gastrointest. Liver Physiol.
297: G559-G566
[Abstract][Full Text]
Sangaletti, S., Colombo, M. P.
(2009). Macrophages Orchestrate the Tumor Microenvironment. aacredbook
2009: 209-214
[Full Text]
Greenhough, A., Smartt, H. J.M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., Kaidi, A.
(2009). The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis
30: 377-386
[Abstract][Full Text]
Husvik, C., Khuu, C., Bryne, M., Halstensen, T.S.
(2009). PGE2 Production in Oral Cancer Cell Lines is COX-2-dependent. JDR
88: 164-169
[Abstract][Full Text]
Liou, J.-Y., Wu, C.-C., Chen, B.-R., Yen, L. B., Wu, K. K.
(2008). Nonsteroidal Anti-Inflammatory Drugs Induced Endothelial Apoptosis by Perturbing Peroxisome Proliferator-Activated Receptor-{delta} Transcriptional Pathway. Mol. Pharmacol.
74: 1399-1406
[Abstract][Full Text]
Howe, L. R., Lippman, S. M.
(2008). Modulation of Breast Cancer Risk by Nonsteroidal Anti-inflammatory Drugs. JNCI J Natl Cancer Inst
100: 1420-1423
[Full Text]
Macias-Perez, I. M., Zent, R., Carmosino, M., Breyer, M. D., Breyer, R. M., Pozzi, A.
(2008). Mouse EP3 {alpha}, {beta}, and {gamma} Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis in Vivo. J. Biol. Chem.
283: 12538-12545
[Abstract][Full Text]
Allred, C. D., Talbert, D. R., Southard, R. C., Wang, X., Kilgore, M. W.
(2008). PPAR{gamma}1 as a Molecular Target of Eicosapentaenoic Acid in Human Colon Cancer (HT-29) Cells. J. Nutr.
138: 250-256
[Abstract][Full Text]
Izzo, J. G., Ajani, J. A.
(2007). Thinking In and Out of the Box When It Comes to Gastric Cancer and Cyclooxygenase-2. JCO
25: 4865-4867
[Full Text]
Kune, G.
(2007). Commentary: Aspirin and cancer prevention. Int J Epidemiol
0: dym194v1-dym194
[Full Text]
Logan, R.
(2007). Commentary: Preventing colorectal cancer with aspirin what next?. Int J Epidemiol
0: dym204v1-dym204
[Full Text]
Di Mari, J. F., Saada, J. I., Mifflin, R. C., Valentich, J. D., Powell, D. W.
(2007). HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol.
293: G719-G728
[Abstract][Full Text]
Iwase, N., Higuchi, T., Gonda, T., Kobayashi, H., Uetake, H., Enomoto, M., Sugihara, K.
(2007). The Effect of Meloxicam, a Selective COX-2 Inhibitor, on the Microvasculature of Small Metastatic Liver Tumors in Rats. Jpn J Clin Oncol
37: 673-678
[Abstract][Full Text]
Tan, W., Wu, J., Zhang, X., Guo, Y., Liu, J., Sun, T., Zhang, B., Zhao, D., Yang, M., Yu, D., Lin, D.
(2007). Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis
28: 1197-1201
[Abstract][Full Text]
Markowitz, S. D.
(2007). Aspirin and Colon Cancer -- Targeting Prevention?. NEJM
356: 2195-2198
[Full Text]
Chan, A. T., Manson, J. E., Feskanich, D., Stampfer, M. J., Colditz, G. A., Fuchs, C. S.
(2007). Long-term Aspirin Use and Mortality in Women. Arch Intern Med
167: 562-572
[Abstract][Full Text]
U.S. Preventive Services Task Force*,
(2007). Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. ANN INTERN MED
146: 361-364
[Abstract][Full Text]
Dube, C., Rostom, A., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., Moher, D.
(2007). The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force. ANN INTERN MED
146: 365-375
[Abstract][Full Text]
Tong, X., Van Dross, R. T., Abu-Yousif, A., Morrison, A. R., Pelling, J. C.
(2007). Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition. Mol. Cell. Biol.
27: 283-296
[Abstract][Full Text]
Jewett, A., Head, C., Cacalano, N.A.
(2006). Emerging Mechanisms of Immunosuppression in Oral Cancers. JDR
85: 1061-1073
[Abstract][Full Text]
Monjazeb, A. M., High, K. P., Connoy, A., Hart, L. S., Koumenis, C., Chilton, F. H.
(2006). Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis
27: 1950-1960
[Abstract][Full Text]
Allison, M., Garland, C., Chlebowski, R., Criqui, M., Langer, R., Wu, L., Roy, H., McTiernan, A., Kuller, L., for the Women's Health Initiative Investigators,
(2006). The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women. Am J Epidemiol
164: 567-575
[Abstract][Full Text]
Brunelle, M., Sartin, E. A., Wolfe, L. G., Sirois, J., Dore, M.
(2006). Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.. Vet Pathol
43: 656-666
[Abstract][Full Text]
Flick, E. D., Chan, K. A., Bracci, P. M., Holly, E. A.
(2006). Use of Nonsteroidal Antiinflammatory Drugs and Non-Hodgkin Lymphoma: A Population-based Case-Control Study. Am J Epidemiol
164: 497-504
[Abstract][Full Text]
Chia, V. M., Newcomb, P. A., Bigler, J., Morimoto, L. M., Thibodeau, S. N., Potter, J. D.
(2006). Risk of Microsatellite-Unstable Colorectal Cancer Is Associated Jointly with Smoking and Nonsteroidal Anti-inflammatory Drug Use.. Cancer Res.
66: 6877-6883
[Abstract][Full Text]
Perrone, G, Santini, D, Verzi, A, Vincenzi, B, Borzomati, D, Vecchio, F, Coppola, R, Antinori, A, Magistrelli, P, Tonini, G, Rabitti, C
(2006). COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables. J. Clin. Pathol.
59: 492-496
[Abstract][Full Text]
Holla, V. R., Mann, J. R., Shi, Q., DuBois, R. N.
(2006). Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer. J. Biol. Chem.
281: 2676-2682
[Abstract][Full Text]
Tanaka, S, Tatsuguchi, A, Futagami, S, Gudis, K, Wada, K, Seo, T, Mitsui, K, Yonezawa, M, Nagata, K, Fujimori, S, Tsukui, T, Kishida, T, Sakamoto, C
(2006). Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut
55: 54-61
[Abstract][Full Text]
Mazhar, D., Gillmore, R., Waxman, J.
(2005). COX and cancer. QJM
98: 711-718
[Full Text]
Gasparini, G., Gattuso, D., Morabito, A., Longo, R., Torino, F., Sarmiento, R., Vitale, S., Gamucci, T., Mariani, L.
(2005). Combined Therapy with Weekly Irinotecan, Infusional 5-Fluorouracil and the Selective COX-2 Inhibitor Rofecoxib Is a Safe and Effective Second-Line Treatment in Metastatic Colorectal Cancer. The Oncologist
10: 710-717
[Abstract][Full Text]
Clines, G A, Guise, T A
(2005). Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer
12: 549-583
[Abstract][Full Text]
Choe, M. S., Zhang, X., Shin, H. J. C., Shin, D. M., Chen, Z.
(2005). Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer. Molecular Cancer Therapeutics
4: 1448-1455
[Abstract][Full Text]
Hughes-Fulford, M., Tjandrawinata, R. R., Li, C.-F., Sayyah, S.
(2005). Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. Carcinogenesis
26: 1520-1526
[Abstract][Full Text]
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Curhan, G. C., Fuchs, C. S.
(2005). Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer. JAMA
294: 914-923
[Abstract][Full Text]
Kovacs, G. G., Zsembery, A., Anderson, S. J., Komlosi, P., Gillespie, G. Y., Bell, P. D., Benos, D. J., Fuller, C. M.
(2005). Changes in intracellular Ca2+ and pH in response to thapsigargin in human glioblastoma cells and normal astrocytes. Am. J. Physiol. Cell Physiol.
289: C361-C371
[Abstract][Full Text]
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., Salvemini, D.
(2005). Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors. Pharmacol. Rev.
57: 217-252
[Abstract][Full Text]
Brown, J. R., DuBois, R. N.
(2005). COX-2: A Molecular Target for Colorectal Cancer Prevention. JCO
23: 2840-2855
[Abstract][Full Text]
Sangha, S, Yao, M, Wolfe, M M
(2005). Non-steroidal anti-inflammatory drugs and colorectal cancer prevention. Postgrad. Med. J.
81: 223-227
[Abstract][Full Text]
Kojima, M., Wakai, K., Tokudome, S., Suzuki, K., Tamakoshi, K., Watanabe, Y., Kawado, M., Hashimoto, S., Hayakawa, N., Ozasa, K., Toyoshima, H., Suzuki, S., Ito, Y., Tamakoshi, A., for the JACC Study Group,
(2005). Serum Levels of Polyunsaturated Fatty Acids and Risk of Colorectal Cancer: A Prospective Study. Am J Epidemiol
161: 462-471
[Abstract][Full Text]
Lindblad, M., Lagergren, J., Garcia Rodriguez, L. A.
(2005). Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Cancer. Cancer Epidemiol. Biomarkers Prev.
14: 444-450
[Abstract][Full Text]
Illmer, C., Madlener, S., Horvath, Z., Saiko, P., Losert, A., Herbacek, I., Grusch, M., Krupitza, G., Fritzer-Szekeres, M., Szekeres, T.
(2005). Immunologic and Biochemical Effects of the Fermented Wheat Germ Extract Avemar. Exp. Biol. Med.
230: 144-149
[Abstract][Full Text]
Kawamori, T., Kitamura, T., Watanabe, K., Uchiya, N., Maruyama, T., Narumiya, S., Sugimura, T., Wakabayashi, K.
(2005). Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development. Carcinogenesis
26: 353-357
[Abstract][Full Text]
Hull, M.L., Prentice, A., Wang, D.Y., Butt, R.P., Phillips, S.C., Smith, S.K., Charnock-Jones, D.S.
(2005). Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod
20: 350-358
[Abstract][Full Text]
Hawk, E. T., Levin, B.
(2005). Colorectal Cancer Prevention. JCO
23: 378-391
[Abstract][Full Text]
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirouskova, M., Degen, J. L.
(2005). Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood
105: 178-185
[Abstract][Full Text]
Soumaoro, L. T., Uetake, H., Higuchi, T., Takagi, Y., Enomoto, M., Sugihara, K.
(2004). Cyclooxygenase-2 Expression: A Significant Prognostic Indicator for Patients With Colorectal Cancer. Clin. Cancer Res.
10: 8465-8471
[Abstract][Full Text]
Goodman, J. E., Bowman, E. D., Chanock, S. J., Alberg, A. J., Harris, C. C.
(2004). Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis
25: 2467-2472
[Abstract][Full Text]
Whelan, J., McEntee, M. F.
(2004). Dietary (n-6) PUFA and Intestinal Tumorigenesis. J. Nutr.
134: 3421S-3426S
[Abstract][Full Text]
Keith, R. L., Miller, Y. E., Hudish, T. M., Girod, C. E., Sotto-Santiago, S., Franklin, W. A., Nemenoff, R. A., March, T. H., Nana-Sinkam, S. P., Geraci, M. W.
(2004). Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice. Cancer Res.
64: 5897-5904
[Abstract][Full Text]
Hardwick, J. C. H., van Santen, M., van den Brink, G. R., van Deventer, S. J. H., Peppelenbosch, M. P.
(2004). DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis
25: 1293-1298
[Abstract][Full Text]
Kelloff, G. J., Schilsky, R. L., Alberts, D. S., Day, R. W., Guyton, K. Z., Pearce, H. L., Peck, J. C., Phillips, R., Sigman, C. C.
(2004). Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs. Clin. Cancer Res.
10: 3908-3918
[Full Text]
Rhee, J. C., Khuri, F. R., Shin, D. M.
(2004). Advances in Chemoprevention of Head and Neck Cancer. The Oncologist
9: 302-311
[Abstract][Full Text]
Jacobs, E. J., Connell, C. J., Rodriguez, C., Patel, A. V., Calle, E. E., Thun, M. J.
(2004). Aspirin Use and Pancreatic Cancer Mortality in a Large United States Cohort. JNCI J Natl Cancer Inst
96: 524-528
[Abstract][Full Text]
Wu, T., Leng, J., Han, C., Demetris, A. J.
(2004). The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Molecular Cancer Therapeutics
3: 299-307
[Abstract][Full Text]
Poullis, A., Foster, R., Shetty, A., Fagerhol, M. K., Mendall, M. A.
(2004). Bowel Inflammation as Measured by Fecal Calprotectin: A Link between Lifestyle Factors and Colorectal Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
13: 279-284
[Abstract][Full Text]
Swamy, M. V., Cooma, I., Patlolla, J. M.R., Simi, B., Reddy, B. S., Rao, C. V.
(2004). Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: Novel strategies for colon cancer prevention and treatment. Molecular Cancer Therapeutics
3: 215-221
[Abstract][Full Text]
MacDonald, C. J., Ciolino, H. P., Yeh, G. C.
(2004). The Drug Salicylamide Is an Antagonist of the Aryl Hydrocarbon Receptor That Inhibits Signal Transduction Induced by 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Cancer Res.
64: 429-434
[Abstract][Full Text]
Lieberman, D. A., Prindiville, S., Weiss, D. G., Willett, W.
(2003). Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals. JAMA
290: 2959-2967
[Abstract][Full Text]
Wang, W. H., Huang, J. Q., Zheng, G. F., Lam, S. K., Karlberg, J., Wong, B. C.-Y.
(2003). Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis. JNCI J Natl Cancer Inst
95: 1784-1791
[Abstract][Full Text]
Sato, T., Yoshinaga, K., Okabe, S., Okawa, T., Higuchi, T., Enomoto, M., Takizawa, T., Sugihara, K.
(2003). Cyclooxygenase-2 Expression and its Relationship with Proliferation of Colorectal Adenomas. Jpn J Clin Oncol
33: 631-635
[Abstract][Full Text]
Sengupta, S., Sellers, L. A., Cindrova, T., Skepper, J., Gherardi, E., Sasisekharan, R., Fan, T.-P. D.
(2003). Cyclooxygenase-2-selective Nonsteroidal Anti-Inflammatory Drugs Inhibit Hepatocyte Growth Factor/Scatter Factor-induced Angiogenesis. Cancer Res.
63: 8351-8359
[Abstract][Full Text]
Herendeen, J. M, Lindley, C.
(2003). Use of NSAIDs for the Chemoprevention of Colorectal Cancer. The Annals of Pharmacotherapy
37: 1664-1674
[Abstract][Full Text]
Yasumaru, M., Tsuji, S., Tsujii, M., Irie, T., Komori, M., Kimura, A., Nishida, T., Kakiuchi, Y., Kawai, N., Murata, H., Horimoto, M., Sasaki, Y., Hayashi, N., Kawano, S., Hori, M.
(2003). Inhibition of Angiotensin II Activity Enhanced the Antitumor Effect of Cyclooxygenase-2 Inhibitors via Insulin-Like Growth Factor I Receptor Pathway. Cancer Res.
63: 6726-6734
[Abstract][Full Text]
Higuchi, T., Iwama, T., Yoshinaga, K., Toyooka, M., Taketo, M. M., Sugihara, K.
(2003). A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Rofecoxib, a Selective Cyclooxygenase-2 Inhibitor, on Rectal Polyps in Familial Adenomatous Polyposis Patients. Clin. Cancer Res.
9: 4756-4760
[Abstract][Full Text]
Takeda, H., Sonoshita, M., Oshima, H., Sugihara, K.-i., Chulada, P. C., Langenbach, R., Oshima, M., Taketo, M. M.
(2003). Cooperation of Cyclooxygenase 1 and Cyclooxygenase 2 in Intestinal Polyposis. Cancer Res.
63: 4872-4877
[Abstract][Full Text]
Davies, G., Salter, J., Hills, M., Martin, L.-A., Sacks, N., Dowsett, M.
(2003). Correlation between Cyclooxygenase-2 Expression and Angiogenesis in Human Breast Cancer. Clin. Cancer Res.
9: 2651-2656
[Abstract][Full Text]
Fukuda, R., Kelly, B., Semenza, G. L.
(2003). Vascular Endothelial Growth Factor Gene Expression in Colon Cancer Cells Exposed to Prostaglandin E2 Is Mediated by Hypoxia-inducible Factor 1. Cancer Res.
63: 2330-2334
[Abstract][Full Text]
Miyata, Y., Koga, S., Kanda, S., Nishikido, M., Hayashi, T., Kanetake, H.
(2003). Expression of Cyclooxygenase-2 in Renal Cell Carcinoma: Correlation with Tumor Cell Proliferation, Apoptosis, Angiogenesis, Expression of Matrix Metalloproteinase-2, and Survival. Clin. Cancer Res.
9: 1741-1749
[Abstract][Full Text]
Sawaoka, H., Dixon, D. A., Oates, J. A., Boutaud, O.
(2003). Tristetraprolin Binds to the 3'-Untranslated Region of Cyclooxygenase-2 mRNA. A POLYADENYLATION VARIANT IN A CANCER CELL LINE LACKS THE BINDING SITE. J. Biol. Chem.
278: 13928-13935
[Abstract][Full Text]
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., Steinbach, G., Schilsky, R.
(2003). A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer. NEJM
348: 883-890
[Abstract][Full Text]
Dommels, Y. E.M., Haring, M. M.G., Keestra, N. G.M., Alink, G. M., van Bladeren, P. J., van Ommen, B.
(2003). The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE2 synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis
24: 385-392
[Abstract][Full Text]
Callejas, N. A., Fernandez-Martinez, A., Castrillo, A., Bosca, L., Martin-Sanz, P.
(2003). Selective Inhibitors of Cyclooxygenase-2 Delay the Activation of Nuclear Factor kappa B and Attenuate the Expression of Inflammatory Genes in Murine Macrophages Treated with Lipopolysaccharide. Mol. Pharmacol.
63: 671-677
[Abstract][Full Text]
Henry, C. J., McCaw, D. L., Turnquist, S. E., Tyler, J. W., Bravo, L., Sheafor, S., Straw, R. C., Dernell, W. S., Madewell, B. R., Jorgensen, L., Scott, M. A., Higginbotham, M. L., Chun, R.
(2003). Clinical Evaluation of Mitoxantrone and Piroxicam in a Canine Model of Human Invasive Urinary Bladder Carcinoma. Clin. Cancer Res.
9: 906-911
[Abstract][Full Text]
Koeffler, H. P.
(2003). Peroxisome Proliferator-activated Receptor {gamma} and Cancers. Clin. Cancer Res.
9: 1-9
[Abstract][Full Text]
Johnson, T. W., Anderson, K. E., Lazovich, D., Folsom, A. R.
(2002). Association of Aspirin and Nonsteroidal Anti-inflammatory Drug Use with Breast Cancer. Cancer Epidemiol. Biomarkers Prev.
11: 1586-1591
[Abstract][Full Text]
Bair, W. B. III, Hart, N., Einspahr, J., Liu, G., Dong, Z., Alberts, D., Bowden, G. T.
(2002). Inhibitory Effects of Sodium Salicylate and Acetylsalicylic Acid on UVB-induced Mouse Skin Carcinogenesis. Cancer Epidemiol. Biomarkers Prev.
11: 1645-1652
[Abstract][Full Text]
Sun, Y., Tang, X. M., Half, E., Kuo, M. T., Sinicrope, F. A.
(2002). Cyclooxygenase-2 Overexpression Reduces Apoptotic Susceptibility by Inhibiting the Cytochrome c-dependent Apoptotic Pathway in Human Colon Cancer Cells. Cancer Res.
62: 6323-6328
[Abstract][Full Text]
Trifan, O. C., Durham, W. F., Salazar, V. S., Horton, J., Levine, B. D., Zweifel, B. S., Davis, T. W., Masferrer, J. L.
(2002). Cyclooxygenase-2 Inhibition with Celecoxib Enhances Antitumor Efficacy and Reduces Diarrhea Side Effect of CPT-11. Cancer Res.
62: 5778-5784
[Abstract][Full Text]
Rossi, D. J., Ylikorkala, A., Korsisaari, N., Salovaara, R., Luukko, K., Launonen, V., Henkemeyer, M., Ristimaki, A., Aaltonen, L. A., Makela, T. P.
(2002). Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc. Natl. Acad. Sci. USA
99: 12327-12332
[Abstract][Full Text]
Gugliucci, A., Ranzato, L., Scorrano, L., Colonna, R., Petronilli, V., Cusan, C., Prato, M., Mancini, M., Pagano, F., Bernardi, P.
(2002). Mitochondria Are Direct Targets of the Lipoxygenase Inhibitor MK886. A STRATEGY FOR CELL KILLING BY COMBINED TREATMENT WITH MK886 AND CYCLOOXYGENASE INHIBITORS. J. Biol. Chem.
277: 31789-31795
[Abstract][Full Text]
Anderson, K. E., Johnson, T. W., Lazovich, D., Folsom, A. R.
(2002). Association Between Nonsteroidal Anti-Inflammatory Drug Use and the Incidence of Pancreatic Cancer. JNCI J Natl Cancer Inst
94: 1168-1171
[Abstract][Full Text]
Vaughan, T. L., Kristal, A. R., Blount, P. L., Levine, D. S., Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Rabinovitch, P. S., Reid, B. J.
(2002). Nonsteroidal Anti-inflammatory Drug Use, Body Mass Index, and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev.
11: 745-752
[Abstract][Full Text]
Sunayama, K.-i., Konno, H., Nakamura, T., Kashiwabara, H., Shoji, T., Tsuneyoshi, T., Nakamura, S.
(2002). The role of cyclooxygenase-2 (COX-2) in two different morphological stages of intestinal polyps in APC{Delta}474 knockout mice. Carcinogenesis
23: 1351-1359
[Abstract][Full Text]
Yamazaki, R., Kusunoki, N., Matsuzaki, T., Hashimoto, S., Kawai, S.
(2002). Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Association with Activation of Peroxisome Proliferator-Activated Receptor gamma in Rheumatoid Synovial Cells. J. Pharmacol. Exp. Ther.
302: 18-25
[Abstract][Full Text]
Phillips, R K S, Wallace, M H, Lynch, P M, Hawk, E, Gordon, G B, Saunders, B P, Wakabayashi, N, Shen, Y, Zimmerman, S, Godio, L, Rodrigues-Bigas, M, Su, L-K, Sherman, J, Kelloff, G, Levin, B, Steinbach, G
(2002). A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut
50: 857-860
[Abstract][Full Text]
Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J., Sessoms, A., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., Langenbach, R.
(2002). Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis. Cancer Res.
62: 3395-3401
[Abstract][Full Text]
Tsunozaki, H., Yoshinaga, K., Kumagai, J., Sugihara, K.
(2002). Cyclooxygenase-2 Overexpression in Colorectal Cancer is Associated with Non-polypoid Growth. Jpn J Clin Oncol
32: 167-171
[Abstract][Full Text]
Davies, G., Martin, L.-A., Sacks, N., Dowsett, M.
(2002). Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol
13: 669-678
[Abstract][Full Text]
Sample, D., Wargovich, M., Fischer, S. M., Inamdar, N., Schwartz, P., Wang, X., Do, K.-A., Sinicrope, F. A., Day, N. E., Shuker, D. E. G., Bingham, S. A.
(2002). A Dose-finding Study of Aspirin for Chemoprevention Utilizing Rectal Mucosal Prostaglandin E2 Levels as a Biomarker. Cancer Epidemiol. Biomarkers Prev.
11: 275-279
[Abstract][Full Text]
Half, E., Tang, X. M., Gwyn, K., Sahin, A., Wathen, K., Sinicrope, F. A.
(2002). Cyclooxygenase-2 Expression in Human Breast Cancers and Adjacent Ductal Carcinoma in Situ. Cancer Res.
62: 1676-1681
[Abstract][Full Text]
Thun, M. J., Henley, S. J., Patrono, C.
(2002). Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues. JNCI J Natl Cancer Inst
94: 252-266
[Abstract][Full Text]
Keith, R. L., Miller, Y. E., Hoshikawa, Y., Moore, M. D., Gesell, T. L., Gao, B., Malkinson, A. M., Golpon, H. A., Nemenoff, R. A., Geraci, M. W.
(2002). Manipulation of Pulmonary Prostacyclin Synthase Expression Prevents Murine Lung Cancer. Cancer Res.
62: 734-740
[Abstract][Full Text]
Kripke, D. F., Garfinkel, L., Wingard, D. L., Klauber, M. R., Marler, M. R.
(2002). Mortality Associated With Sleep Duration and Insomnia. Arch Gen Psychiatry
59: 131-136
[Abstract][Full Text]
O'Shaughnessy, J. A., Kelloff, G. J., Gordon, G. B., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S., Nelson, W. G., Meyskens, F. L., Alberts, D. S., Follen, M., Rustgi, A. K., Papadimitrakopoulou, V., Scardino, P. T., Gazdar, A. F., Wattenberg, L. W., Sporn, M. B., Sakr, W. A., Lippman, S. M., Von Hoff, D. D.
(2002). Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia. Clin. Cancer Res.
8: 314-346
[Abstract][Full Text]
Collaboration, A. T.
(2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ
324: 71-86
[Abstract][Full Text]
Rodriguez-Burford, C., Barnes, M. N., Oelschlager, D. K., Myers, R. B., Talley, L. I., Partridge, E. E., Grizzle, W. E.
(2002). Effects of Nonsteroidal Anti-Inflammatory Agents (NSAIDs) on Ovarian Carcinoma Cell Lines: Preclinical Evaluation of NSAIDs as Chemopreventive Agents. Clin. Cancer Res.
8: 202-209
[Abstract][Full Text]
